Enz W, Jeunet F
Medical Department, F. Hoffmann-La Roche & Co. Ltd. Basle, Switzerland.
Scand J Rheumatol Suppl. 1989;80:54-8. doi: 10.3109/03009748909103713.
Tenoxicam milk formulation is a new galenical form of a non-steroidal anti-inflammatory drug (NSAID). It is especially suitable for patients having compliance problems or difficulty in swallowing tablets. This formulation has proved to be a useful alternative oral treatment in various rheumatic conditions. Combining rapid onset of action and maintenance of active plasma levels, tenoxicam achieved good clinical efficacy and tolerability in the vast majority of the patients studied.
替诺昔康乳剂是一种新型的非甾体抗炎药(NSAID)剂型。它特别适用于有服药依从性问题或吞咽片剂困难的患者。该剂型已被证明是各种风湿性疾病中一种有效的替代口服治疗方法。替诺昔康兼具起效迅速和维持有效血浆浓度的特点,在绝大多数研究对象中都取得了良好的临床疗效和耐受性。